Buratti Franca M, Testai Emanuela
Istituto Superiore di Sanità, Environment and Primary Prevention Department - Mechanism of Toxicity Unit, Viale Regina Elena 299, I-00161 Rome, Italy.
Istituto Superiore di Sanità, Environment and Primary Prevention Department - Mechanism of Toxicity Unit, Viale Regina Elena 299, I-00161 Rome, Italy.
Toxicol Lett. 2015 Jan 5;232(1):133-40. doi: 10.1016/j.toxlet.2014.10.020. Epub 2014 Oct 17.
The accepted pathway for MC biotransformation is GSH conjugation, occurring either spontaneously or catalyzed by GST. In the present work, the already available information on human MC metabolism have been expanded and the capacity of human GST to conjugate MC-LR has been confirmed in human liver cytosol. At physiological GSH content the spontaneous reaction predominated on the enzymatic one; the prevalence of the enzymatic reaction occurred following GSH depletion, and the shift was detectable at higher GSH levels, the lower was MC concentration. However, at low MC-LR concentrations (≤10μM), representative of repeated oral exposure, the relevance of the enzymatic reaction became predominant at GSH concentration between 1 and 2mM. MC-LR conjugate was detectable at ≥0.5mM GSH, whereas, with 10μM MC-RR detectable levels of conjugate were observed at 0.05mM GSH, a 10-fold lower concentration. Overall, our data indicate that MC-RR is more efficiently conjugated than MC-LR, especially at low concentrations. Cytosol samples from rat and mouse were used to characterize GSH conjugation of MC-LR and MC-RR, and to check for possible species differences. At physiological GSH content, in both rodent species the enzymatic reaction accounted for half of the total conjugate formation, reducing the impact of spontaneous reaction with respect to human. Rat and mouse GST showed similar MC-LR and-RR GSH conjugation, but a two-fold higher catalytic efficiency than human sample. This is mainly due to higher affinity for the substrate, with Kmapp values being an order of magnitude lower in the animal models than in human liver cytosol. More pronounced differences in the metabolism of the two variants were evidenced in rodents than in humans.
微囊藻毒素(MC)生物转化公认的途径是谷胱甘肽(GSH)结合反应,该反应可自发发生或由谷胱甘肽S-转移酶(GST)催化。在本研究中,已有的关于人类MC代谢的信息得到了扩展,并且在人肝细胞溶胶中证实了人GST结合MC-LR的能力。在生理GSH含量下,自发反应比酶促反应更占优势;在GSH耗竭后酶促反应占主导,并且在较高的GSH水平下这种转变是可检测到的,MC浓度越低越明显。然而,在低MC-LR浓度(≤10μM)下,这代表重复口服暴露,在GSH浓度为1至2mM时酶促反应的相关性变得占主导。在GSH≥0.5mM时可检测到MC-LR结合物,而对于10μM的MC-RR,在0.05mM GSH时可观察到结合物的可检测水平,浓度低10倍。总体而言,我们的数据表明MC-RR比MC-LR更有效地结合,特别是在低浓度时。使用大鼠和小鼠的细胞溶胶样品来表征MC-LR和MC-RR的GSH结合,并检查可能的物种差异。在生理GSH含量下,在两种啮齿动物物种中酶促反应占总结合物形成的一半,相对于人类减少了自发反应的影响。大鼠和小鼠的GST显示出相似的MC-LR和-RR GSH结合,但催化效率比人类样品高两倍。这主要是由于对底物的亲和力更高,动物模型中的表观米氏常数(Kmapp)值比人肝细胞溶胶低一个数量级。与人类相比,在啮齿动物中两种变体的代谢差异更明显。